Cargando…

A multi-omics study of circulating phospholipid markers of blood pressure

High-throughput techniques allow us to measure a wide-range of phospholipids which can provide insight into the mechanisms of hypertension. We aimed to conduct an in-depth multi-omics study of various phospholipids with systolic blood pressure (SBP) and diastolic blood pressure (DBP). The associatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jun, de Vries, Paul S., Del Greco M., Fabiola, Johansson, Åsa, Schraut, Katharina E., Hayward, Caroline, van Dijk, Ko Willems, Franco, Oscar. H., Hicks, Andrew A., Vitart, Veronique, Rudan, Igor, Campbell, Harry, Polašek, Ozren, Pramstaller, Peter P., Wilson, James F., Gyllensten, Ulf, van Duijn, Cornelia M., Dehghan, Abbas, Demirkan, Ayşe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755711/
https://www.ncbi.nlm.nih.gov/pubmed/35022422
http://dx.doi.org/10.1038/s41598-021-04446-7
_version_ 1784632427452301312
author Liu, Jun
de Vries, Paul S.
Del Greco M., Fabiola
Johansson, Åsa
Schraut, Katharina E.
Hayward, Caroline
van Dijk, Ko Willems
Franco, Oscar. H.
Hicks, Andrew A.
Vitart, Veronique
Rudan, Igor
Campbell, Harry
Polašek, Ozren
Pramstaller, Peter P.
Wilson, James F.
Gyllensten, Ulf
van Duijn, Cornelia M.
Dehghan, Abbas
Demirkan, Ayşe
author_facet Liu, Jun
de Vries, Paul S.
Del Greco M., Fabiola
Johansson, Åsa
Schraut, Katharina E.
Hayward, Caroline
van Dijk, Ko Willems
Franco, Oscar. H.
Hicks, Andrew A.
Vitart, Veronique
Rudan, Igor
Campbell, Harry
Polašek, Ozren
Pramstaller, Peter P.
Wilson, James F.
Gyllensten, Ulf
van Duijn, Cornelia M.
Dehghan, Abbas
Demirkan, Ayşe
author_sort Liu, Jun
collection PubMed
description High-throughput techniques allow us to measure a wide-range of phospholipids which can provide insight into the mechanisms of hypertension. We aimed to conduct an in-depth multi-omics study of various phospholipids with systolic blood pressure (SBP) and diastolic blood pressure (DBP). The associations of blood pressure and 151 plasma phospholipids measured by electrospray ionization tandem mass spectrometry were performed by linear regression in five European cohorts (n = 2786 in discovery and n = 1185 in replication). We further explored the blood pressure-related phospholipids in Erasmus Rucphen Family (ERF) study by associating them with multiple cardiometabolic traits (linear regression) and predicting incident hypertension (Cox regression). Mendelian Randomization (MR) and phenome-wide association study (Phewas) were also explored to further investigate these association results. We identified six phosphatidylethanolamines (PE 38:3, PE 38:4, PE 38:6, PE 40:4, PE 40:5 and PE 40:6) and two phosphatidylcholines (PC 32:1 and PC 40:5) which together predicted incident hypertension with an area under the ROC curve (AUC) of 0.61. The identified eight phospholipids are strongly associated with triglycerides, obesity related traits (e.g. waist, waist-hip ratio, total fat percentage, body mass index, lipid-lowering medication, and leptin), diabetes related traits (e.g. glucose, insulin resistance and insulin) and prevalent type 2 diabetes. The genetic determinants of these phospholipids also associated with many lipoproteins, heart rate, pulse rate and blood cell counts. No significant association was identified by bi-directional MR approach. We identified eight blood pressure-related circulating phospholipids that have a predictive value for incident hypertension. Our cross-omics analyses show that phospholipid metabolites in the circulation may yield insight into blood pressure regulation and raise a number of testable hypothesis for future research.
format Online
Article
Text
id pubmed-8755711
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-87557112022-01-13 A multi-omics study of circulating phospholipid markers of blood pressure Liu, Jun de Vries, Paul S. Del Greco M., Fabiola Johansson, Åsa Schraut, Katharina E. Hayward, Caroline van Dijk, Ko Willems Franco, Oscar. H. Hicks, Andrew A. Vitart, Veronique Rudan, Igor Campbell, Harry Polašek, Ozren Pramstaller, Peter P. Wilson, James F. Gyllensten, Ulf van Duijn, Cornelia M. Dehghan, Abbas Demirkan, Ayşe Sci Rep Article High-throughput techniques allow us to measure a wide-range of phospholipids which can provide insight into the mechanisms of hypertension. We aimed to conduct an in-depth multi-omics study of various phospholipids with systolic blood pressure (SBP) and diastolic blood pressure (DBP). The associations of blood pressure and 151 plasma phospholipids measured by electrospray ionization tandem mass spectrometry were performed by linear regression in five European cohorts (n = 2786 in discovery and n = 1185 in replication). We further explored the blood pressure-related phospholipids in Erasmus Rucphen Family (ERF) study by associating them with multiple cardiometabolic traits (linear regression) and predicting incident hypertension (Cox regression). Mendelian Randomization (MR) and phenome-wide association study (Phewas) were also explored to further investigate these association results. We identified six phosphatidylethanolamines (PE 38:3, PE 38:4, PE 38:6, PE 40:4, PE 40:5 and PE 40:6) and two phosphatidylcholines (PC 32:1 and PC 40:5) which together predicted incident hypertension with an area under the ROC curve (AUC) of 0.61. The identified eight phospholipids are strongly associated with triglycerides, obesity related traits (e.g. waist, waist-hip ratio, total fat percentage, body mass index, lipid-lowering medication, and leptin), diabetes related traits (e.g. glucose, insulin resistance and insulin) and prevalent type 2 diabetes. The genetic determinants of these phospholipids also associated with many lipoproteins, heart rate, pulse rate and blood cell counts. No significant association was identified by bi-directional MR approach. We identified eight blood pressure-related circulating phospholipids that have a predictive value for incident hypertension. Our cross-omics analyses show that phospholipid metabolites in the circulation may yield insight into blood pressure regulation and raise a number of testable hypothesis for future research. Nature Publishing Group UK 2022-01-12 /pmc/articles/PMC8755711/ /pubmed/35022422 http://dx.doi.org/10.1038/s41598-021-04446-7 Text en © Crown 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Liu, Jun
de Vries, Paul S.
Del Greco M., Fabiola
Johansson, Åsa
Schraut, Katharina E.
Hayward, Caroline
van Dijk, Ko Willems
Franco, Oscar. H.
Hicks, Andrew A.
Vitart, Veronique
Rudan, Igor
Campbell, Harry
Polašek, Ozren
Pramstaller, Peter P.
Wilson, James F.
Gyllensten, Ulf
van Duijn, Cornelia M.
Dehghan, Abbas
Demirkan, Ayşe
A multi-omics study of circulating phospholipid markers of blood pressure
title A multi-omics study of circulating phospholipid markers of blood pressure
title_full A multi-omics study of circulating phospholipid markers of blood pressure
title_fullStr A multi-omics study of circulating phospholipid markers of blood pressure
title_full_unstemmed A multi-omics study of circulating phospholipid markers of blood pressure
title_short A multi-omics study of circulating phospholipid markers of blood pressure
title_sort multi-omics study of circulating phospholipid markers of blood pressure
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755711/
https://www.ncbi.nlm.nih.gov/pubmed/35022422
http://dx.doi.org/10.1038/s41598-021-04446-7
work_keys_str_mv AT liujun amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT devriespauls amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT delgrecomfabiola amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT johanssonasa amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT schrautkatharinae amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT haywardcaroline amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT vandijkkowillems amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT francooscarh amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT hicksandrewa amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT vitartveronique amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT rudanigor amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT campbellharry amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT polasekozren amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT pramstallerpeterp amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT wilsonjamesf amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT gyllenstenulf amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT vanduijncorneliam amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT dehghanabbas amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT demirkanayse amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT liujun multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT devriespauls multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT delgrecomfabiola multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT johanssonasa multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT schrautkatharinae multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT haywardcaroline multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT vandijkkowillems multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT francooscarh multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT hicksandrewa multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT vitartveronique multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT rudanigor multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT campbellharry multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT polasekozren multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT pramstallerpeterp multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT wilsonjamesf multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT gyllenstenulf multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT vanduijncorneliam multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT dehghanabbas multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure
AT demirkanayse multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure